News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis International AG (NVS) Says Glivec Has Potential to Treat PAH; Drug Did Not Reach Statistical Significance In Main Target


10/8/2008 7:48:50 AM

ZURICH, Oct 8 (Reuters) - Novartis AG's cancer drug Glivec had the potential to treat a rare heart and lung condition in a mid-stage trial, but did not reach its main target in the study.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES